Tomivosertib
- Generic Name
- Tomivosertib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H20N6O2
- CAS Number
- 1849590-01-7
- Unique Ingredient Identifier
- U2H19X4WBV
- Background
Tomivosertib is under investigation in clinical trial NCT03318562 (A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC).
- Associated Conditions
- -
- Associated Therapies
- -
A Keto Diet Could Enhance Cancer Drug Effectiveness
A ketogenic diet enhanced the effectiveness of targeted cancer therapy in suppressing tumor growth in mice, suggesting personalized drug-diet combinations as potential cancer therapies.
Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer
Tyra Biosciences appoints Dr. Doug Warner as Chief Medical Officer, overseeing clinical portfolio and joining executive management team. Dr. Warner brings 20+ years of clinical development experience in oncology and skeletal diseases.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath